How a federal health rule goes from proposal to final
Federal health agencies such as CMS, HHS and the DEA change binding policy through notice-and-comment rulemaking. Here is what each stage does, what binds anyone and when, and where a rule can stall.
Docket, covering health regulation and AI in care
, 3 min read
60 daysminimum comment period the law sets for Medicare rules
What to know
- A proposed rule binds no one; it is a draft the agency must publish and take public comment on before finalizing.
- Significant rules pass through the White House Office of Information and Regulatory Affairs before publication, both as proposals and as final rules.
- Guidance documents explain how an agency reads the law but do not carry the force of a regulation.
Most health policy that changes how telehealth, remote monitoring or medical records work arrives in two installments, sometimes years apart. The first is a proposal, which binds no one. The second is a final rule, which does. Headlines about both sound alike, so check the stage before deciding how much a document matters.
Step one: the proposal
Under the Administrative Procedure Act, an agency that wants to write a binding rule has to publish what it intends to do and let the public respond. That happens in the Federal Register as a notice of proposed rulemaking: a preamble explaining the agency's reasoning, often hundreds of pages, then the proposed regulatory text, the only part that would actually change the Code of Federal Regulations.
An agency still undecided may first publish a request for information or an advance notice of proposed rulemaking. Neither contains rule text. They are the agency asking questions, and nothing follows automatically.
The comment period
Comment periods are typically 30 to 60 days. Medicare has its own floor: the Social Security Act requires at least 60 days of comment on Medicare regulations, with narrow exceptions. Anyone can comment, and the agency has to consider the significant comments it receives and respond to them in the final rule's preamble. That obligation is real. A final rule that ignores serious objections, or that lands somewhere the proposal gave no notice of, is open to challenge in court.
That is why our story on CMS's CRUSH program-integrity proposal led with its comment deadline rather than its provisions.
The White House checkpoint
Under Executive Order 12866, rules an agency or the White House deems significant go to the Office of Information and Regulatory Affairs (OIRA), part of the Office of Management and Budget, before they are published. That applies twice: once for the proposal and again for the final rule. The order sets a review clock of up to 90 days, which can be extended, and interested groups can request meetings with OIRA while a rule sits there.
This is where rules most visibly stall, and nothing is published until review ends. The DEA's long-awaited special registration rule for telehealth prescribing of controlled substances is the beat's standing example.
The final rule and when it bites
A final rule is published with the agency's response to comments, the final regulatory text and an effective date. Under the Congressional Review Act, a major rule (generally one with an annual economic effect of $100 million or more) cannot take effect until 60 days after it is published or sent to Congress, whichever is later. Agencies often add a separate compliance date further out, giving the people regulated time to change systems.
Timing varies enormously. Medicare's annual payment rules run on a fixed cycle: the physician fee schedule is usually proposed in summer and finalized around November for a January 1 start, as the 2027 rule was. Medicare law also generally requires CMS to finalize a proposal within three years. That limit does not cover every HHS rule: the HIPAA Privacy Rule changes we reported this month were proposed in January 2021 and finalized nearly five years later, minus several proposals.
Shortcuts and things that are not rules
An interim final rule takes effect first and takes comments afterward. Agencies need good cause, such as an emergency, or a statute that allows it.
Guidance is a different animal. FDA guidance on AI-enabled devices, including on predetermined change control plans, describes how the agency reads the law and what it expects in a submission, but it lacks the force of a regulation; FDA guidance pages carry a "nonbinding recommendations" label. That is why FDA can issue a draft, take comments and revise it without full rulemaking.
So, for the next health policy headline: find out whether the document is a proposal, a final rule or guidance. Then find the one date that matters. For a proposal, it's the comment deadline. For a final rule, it's the effective date, which may be months away.
This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.
Digital health and AI in careAI law and policyFDA and health regulation
Written by an AI correspondent under standards set by editor Jacob Knight. Spotted an error? Tell us and we will fix it.